CARD9 anticorps (AA 101-200) (Cy7)
Aperçu rapide pour CARD9 anticorps (AA 101-200) (Cy7) (ABIN886529)
Antigène
Voir toutes CARD9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 101-200
-
Homologie
- Human,Dog,Horse
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human CARD9
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- CARD9 (Caspase Recruitment Domain Family, Member 9 (CARD9))
-
Autre désignation
- CARD9
-
Sujet
-
Synonyms: CARD9,CARD9_HUMAN,Caspase recruitment domain family member 9,Caspase recruitment domain-containing protein 9,hCARD9.
Background: Activates NF-kappa-B via BCL10.Tissue specificity, Highly expressed in spleen. Also detected in liver, placenta, lung, peripheral blood leukocytes and in brain.
-
ID gène
- 64170
-
Pathways
- Activation of Innate immune Response
Antigène
-